China Urges APEC Cooperation as Trade Minister Steps In for Commerce Minister on Urgent Business
Venture Capital Shifts Focus to LowMargin Unglamorous Industries
Inflations Broadening Beyond Oil and Iran These Sectors Show Reaccelerating Price Pressures
Bitcoin Dips Below 76000 as Liquidations and Rate Volatility Fuel Weekly Decline
Social Media Risks for Youth Compared to Smoking by UK Doctors Potential Impact on Tech Sector
Michael Saylor Highlights Tokenization as a Free Market for Yield and Credit
USEG Q1 2026 Earnings EPS Falls Short of Estimates Amid Challenging Conditions
Eagle Point Income Company Inc EIC Q4 2025 Earnings Slight EPS Miss but Stock Holds Steady
PSBD Q1 2026 Earnings Significant EPS Miss Driven by Unrealized Losses
CMPS Q1 2026 Earnings Narrower Loss Drives Positive Investor Sentiment
Agilysys Inc Q1 2026 Earnings EPS Surges Past Consensus by 244 Stock Edges Higher
NWN Q1 2026 Earnings EPS Misses Estimates Amid Operational Headwinds
Sezzle Inc SEZL Slides 25 as Fintech Sector Headwinds Weigh on Sentiment
Oracle ORCL Gains 23 as Cloud Momentum Drives Price Above Key Support
CollPlant Biotechnologies CLGN Slides 667 as Selling Pressure Mounts
BDCIW Warrants Hold Steady at 045 as Support and Resistance Levels Define Trading Range
Champion Homes Inc SKY Rallies 325 as Housing Sector Sentiment Improves
Dow Leads Wall Street Higher as Healthcare and Tech Stocks Rally
ClearOne Inc CLRO Q2 2018 Earnings EPS Surprise Drives Stock Gain Amid Revenue Silence
Cheche Group Inc CCG Tests Key Resistance After 35 Gain
Aspen Aerogels ASPN Q1 2026 Earnings EPS Misses Estimates as Aerogel Leader Posts WiderThanExpected Loss
Fluent Inc FLNT Q1 2026 Earnings EPS Beats Estimates Narrowly as Revenue Remains Unreported
DBRG Q1 2026 Earnings EPS Misses Estimates by 39 Amid Challenging Market
Corvus Pharmaceuticals CRVS Q1 2026 Earnings RD Pipeline Progress Amid Slight EPS Miss
SRTA Q1 2026 Earnings Surprise Profitability Despite No Reported Revenue
Serve Robotics SERV Q1 2026 Earnings WiderThanExpected Losses Highlight Cost Pressures
NervGen Pharma Q3 2025 Earnings Narrowed Loss Meets Estimates But Stock Plunges 43